Mehdi Nikkhah,
Associate Professor of Bioengineering,
Arizona State University
Mehdi Nikkhah is currently an Associate Professor of Biomedical Engineering at the School of Biological and Health Systems Engineering (SBHSE), Arizona State University (ASU). He completed his postdoctoral fellowship training at Harvard Medical School and Brigham and Women’s Hospital. He received his B.S. in mechanical engineering and M.S. degree in biomedical engineering from Tehran Polytechnic University followed by Ph.D. degree in mechanical engineering from Virginia Tech. His lab’s research interest is focused on the integration of micro- and nano-scale technologies, innovative biomaterials, and biology to better understand the mechanisms of human disease progression and to develop regenerative medicine strategies for treatment of organ/tissue failure. Dr. Nikkhah has published more than 75 journal articles (+10,000 citations, H-index of 46), 8 book chapters and 95 peer-reviewed conference papers and holds 10 US patents and invention disclosures. He has received numerous prestigious awards and recognitions during his career including National Academy of Inventors Senior Membership, Arizona Flinn Foundation Award, ASU Biomedical Engineering Outstanding Assistant Professor Award, NSF CAREER Award and so forth. Along with his research endeavors, Dr. Nikkhah is also very passionate to educate the next generation of students and scholars, with specific attention to minority and underrepresented groups, in science and engineering. He has trained more than 65 trainees including postdoctoral fellows, PhD/MS students as well as undergraduate researchers, from a diverse background, in his lab.
Engineering of Organotypic Tissue On-Chip Systems for Disease Modeling and Drug Testing
Wednesday, 14 December 2022 at 10:00
Add to Calendar ▼2022-12-14 10:00:002022-12-14 11:00:00Europe/LondonEngineering of Organotypic Tissue On-Chip Systems for Disease Modeling and Drug TestingOrganoids and Microphysiological Systems 2022 in Long Beach, CaliforniaLong Beach, CaliforniaSELECTBIOenquiries@selectbiosciences.com
Engineering of ex vivo Tissue-On-Chip Technologies and Microphysiological Systems has gained significant attention in recent years for a wide range of applications in disease modeling, drug screening, and personalized medicine. These technologies have immensely benefited the fields of experimental biology and medicine in the ability to address the limitations of animal models by providing precise control over cell-cell, cell-matrix, and cell-microenvironmental factors interactions. In the past few years, we have been extensively involved in the development of next-generation tissue on-chip technologies through the integration of microfluidic systems, 3D biomaterials, and patient-derived cells. We have successfully engineered and validated numerous disease-on-chip models, including tumor-on-chip and heart-on-chip technologies, to study cancer progression and cardiovascular abnormalities. Using these model systems, we have been able to mechanistically investigate how microenvironmental and genetic risk factors lead to disease progression. Additionally, we have shown the capabilities of these model systems for enhanced drug testing. This seminar will provide an overview of our major findings from these projects.
Add to Calendar ▼2022-12-12 00:00:002022-12-14 00:00:00Europe/LondonOrganoids and Microphysiological Systems 2022Organoids and Microphysiological Systems 2022 in Long Beach, CaliforniaLong Beach, CaliforniaSELECTBIOenquiries@selectbiosciences.com
Add to Calendar ▼2022-12-14 10:00:002022-12-14 11:00:00Europe/LondonEngineering of Organotypic Tissue On-Chip Systems for Disease Modeling and Drug TestingOrganoids and Microphysiological Systems 2022 in Long Beach, CaliforniaLong Beach, CaliforniaSELECTBIOenquiries@selectbiosciences.com
